Status:

COMPLETED

Radiation Therapy to the Head in Preventing Brain Metastases in Women Receiving Trastuzumab and Chemotherapy for Metastatic or Locally Advanced Breast Cancer

Lead Sponsor:

Anglo Celtic Cooperative Oncology Group

Conditions:

Breast Cancer

Eligibility:

FEMALE

18+ years

Phase:

PHASE3

Brief Summary

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. It is not yet known whether radiation therapy directed at the head is effective in preventing brain metastases in patients wit...

Detailed Description

OBJECTIVES: * To test if prophylactic cranial radiotherapy delivering 30 Gy in 10 fractions will significantly reduce (from 35% to 21% at 2 years) the incidence of symptomatic brain metastases in pat...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Histologically proven breast carcinoma
  • Metastatic or locally advanced disease
  • Must demonstrate HER2 3+ positivity on IHC or 2+ over-expression and FISH test demonstrating C-erB2 gene amplification
  • No known or suspected brain metastases or CNS disease, as defined by the presence of any of the following key symptoms:
  • Headache
  • Nausea and/or vomiting
  • Clinical signs of raised intracranial pressure
  • Seizures
  • Focal symptoms
  • Cognitive dysfunction
  • Affective disorder
  • Hormone receptor status not specified
  • PATIENT CHARACTERISTICS:
  • Female
  • Postmenopausal status not specified
  • ECOG performance status 0 or 1
  • Patients must a-priori be suitable for trastuzumab (Herceptin®) +/- chemotherapy in terms of bone marrow, hepatic, and renal function
  • No prior history of cerebrovascular disease or neurological disorder including seizures
  • PRIOR CONCURRENT THERAPY:
  • No prior cranial radiotherapy
  • No prior neurosurgery

Exclusion

    Key Trial Info

    Start Date :

    February 1 2007

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    October 1 2010

    Estimated Enrollment :

    390 Patients enrolled

    Trial Details

    Trial ID

    NCT00639366

    Start Date

    February 1 2007

    End Date

    October 1 2010

    Last Update

    August 7 2013

    Active Locations (19)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 5 (19 locations)

    1

    Basildon University Hospital

    Basildon, England, United Kingdom, SS16 5NL

    2

    Ipswich Hospital

    Ipswich, England, United Kingdom, IP4 5PD

    3

    Leeds Cancer Centre at St. James's University Hospital

    Leeds, England, United Kingdom, LS9 7TF

    4

    Royal Liverpool University Hospital

    Liverpool, England, United Kingdom, L7 8XP